GB Patent

GB2404867A — Breath actuated nasal delivery device

Assigned to Optinose AS · Expires 2005-02-16 · 21y expired

What this patent protects

A breath actuated nasal delivery device comprises a delivery unit <B>37</B> actuable to deliver substance on application of a delivery force, a loading unit <B>61</B> actuable to apply the delivery force to the delivery unit <B>37</B>. There is…

USPTO Abstract

A breath actuated nasal delivery device comprises a delivery unit <B>37</B> actuable to deliver substance on application of a delivery force, a loading unit <B>61</B> actuable to apply the delivery force to the delivery unit <B>37</B>. There is a mouthpiece <B>17</B> through which the user exhales. An air channel <B>23</B> is in fluid communication with the mouthpiece <B>17</B>, and disposed within the air channel <B>23</B> is an actuating member <B>89</B> comprising a flexible, bi-stable element <B>91</B> which is actuable between a first non-actuated state and a second actuated state in which the actuating member <B>89</B> actuates the loading unit <B>61</B> to apply the delivery force to the delivery unit <B>37</B> to actuate the same. There may be a nosepiece <B>19</B> which is inserted into a nostril. The invention also includes a delivery unit comprising a loading unit and a biasing element and a restraining member which is configured to be broken on actuation of the loading unit. Also disclosed is a breath actuated delivery device which has a mouthpiece, air channel within the mouthpiece and a flexible diaphragm disposed in the air channel; a delivery device comprising a delivery unit; a method of delivering substance to a nasal airway of a subject comprising providing a delivery unit which is actuable to delivery substance, loading a loading unit and actuating the loading unit to apply a delivery force to the delivery unit to actuate the same.

Drugs covered by this patent

Patent Metadata

Patent number
GB2404867A
Jurisdiction
GB
Classification
Expires
2005-02-16
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.